New specification for steviol glycoside under evaluation by FSANZ
Australia
Aug 30, 2021
FSANZ is evaluating approval of a new specification for the steviol glycoside, rebaudioside I, produced by enzymatic bioconversion of stevia leaf extract. Bioconversion enzymes are derived from a genetically modified yeast strain, Pichia pastoris.
For further information (in English), click on the Link
Re-Regulating Dietary Supplements
USA
Sep 07, 2023
Anvisa proposes to allow D-Ribose in food supplements
Brazil
Sep 06, 2023
FDA Warns of Potentially "Highly Toxic" Weight Loss Products
USA
Sep 05, 2023
TITCK updates requirements for use of health claims on foods and dietary supplements
Turkey
Aug 30, 2023
BFSA publishes Draft Regulation on Health Food, Food for Special Dietary Use, Food for Special Medical Purpose, Prebiotic and Probiotic Food
Bangladesh
Aug 25, 2023
Dietary supplements program, a critical priority for FDA
USA
Aug 14, 2023
New Regulation on Supervision of Health Supplements
Indonesia
Aug 14, 2023
New draft standard on Complementary Foods for Athletes
Saudi Arabia
Aug 10, 2023
Health Canada issues guidelines for supplemented foods
Canada
Aug 10, 2023
New regulations for supplemented foods
Canada
Aug 01, 2023
SAMR publishes test methods for Food and Food Supplements
China
Jul 24, 2023
Hemp-derived CBD products to be authorized soon
USA
Jul 20, 2023
Hydrolyzed collagen to be authorized in dietary supplements
Argentina
Jul 19, 2023
FDA updates the Priority Guidance Topics for Foods Program
USA
Jul 10, 2023
ANMAT updates procedural fees for foods, supplements and FSMP
Argentina
Jul 10, 2023
